Evidence map›Paper›PMID 40879083›Full record

ArticleHealth promotion international2025

Alcohol lobbying in Canada: a quantitative analysis of the federal registry of lobbyists.

Aaron Grinberg, Kate Vallance, Elizabeth K Farkouh, Norman Giesbrecht, Ashley Wettlaufer, Timothy S Naimi

Abstract read
In one paragraph

Article in Health promotion international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aaron GrinbergCanadian Institute for Substance Use Research, University of Victoria, 2300 McKenzie Ave., Room 273, Victoria, BC, Canada V8P 5C2.ORCID 0009-0002-7395-4860
Kate VallanceCanadian Institute for Substance Use Research, University of Victoria, 2300 McKenzie Ave., Room 273, Victoria, BC, Canada V8P 5C2.ORCID 0000-0003-2094-1804
Elizabeth K FarkouhCanadian Institute for Substance Use Research, University of Victoria, 2300 McKenzie Ave., Room 273, Victoria, BC, Canada V8P 5C2.ORCID 0000-0002-7379-058X
Norman GiesbrechtInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, 1001 Queens St. West, Toronto, ON, Canada M6J 1H4.ORCID 0009-0006-9828-8808
Ashley WettlauferInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, 1001 Queens St. West, Toronto, ON, Canada M6J 1H4.ORCID 0000-0003-1762-7021
Timothy S NaimiCanadian Institute for Substance Use Research, University of Victoria, 2300 McKenzie Ave., Room 273, Victoria, BC, Canada V8P 5C2.ORCID 0000-0001-9849-4413

Funding

Fulbright-MITACS Globalink
6 · The paper itself

Abstract

Although alcohol is a leading cause of health and social harms in Canada, policies directed at alleviating the public health burden created by alcohol are rarely adopted and often reversed. This study analyses alcohol-related policy lobbying activity to better understand how lobbying might impact policy development in Canada. This was deemed not human subjects research. A cross-sectional analysis was conducted using data from the federal Canadian Registry of Lobbyists to characterize the frequency and nature of alcohol industry and public health lobbying activities between May 2022 and May 2023. In this period, there was substantially more lobbying activity by alcohol industry representatives compared to public health stakeholders. Over three-quarters of lobby groups represented alcohol industry organizations (n = 13) compared to public health organizations (n = 4), with industry recording a majority of registered lobbyists (81.3%), meetings reported (66.2%), and number of officials lobbied (71.2%). Alcohol industry organizations predominantly lobbied bureaucrats in policy making/governance roles (54.2% of industry meetings), while public health stakeholders mainly lobbied legislators (60.4% of public health meetings). The alcohol industry's dominance in federal lobbying activities may enable corporate influence over alcohol policy development and undermine public health approaches. The nature of lobbying in Canada has international implications for the regulation of a product that is an important commercial determinant of health, showing the potential role lobbying may play in weakening alcohol regulation.

Indexed as

Alcohol DrinkingAlcoholic BeveragesFood IndustryHealth PolicyLobbyingPublic HealthCanadaCross-Sectional StudiesHumansPolicy MakingRegistriesalcohol drinkingCanadacommercial determinants of healthfederal governmentlegislationlobbying

Identifiers

PMID40879083
PMCPMC12395331

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.